Skip to main content
. 2021 Aug 19;11:16849. doi: 10.1038/s41598-021-95948-x

Table 1.

Model performance statistics for survival prediction task and IDH mutation prediction task, evaluated among patients with grade 2 gliomas.

Survival prediction performance: C-index [95% CI]
Without WSI risk score With WSI risk score Difference
None 0.715 [0.569, 0.830]
Age 0.745 [0.627, 0.838] 0.765 [0.643, 0.865] 0.020 [− 0.091, 0.100]
Gender 0.509 [0.345, 0.630] 0.688 [0.528, 0.815] 0.179 [− 0.007, 0.352]
Race 0.520 [0.444, 0.554] 0.713 [0.568, 0.831] 0.193 [0.056, 0.322]*
Primary diagnosis 0.572 [0.437, 0.707] 0.689 [0.539, 0.822] 0.117 [0.003, 0.230]*
IDH mutations 0.692 [0.573, 0.807] 0.762 [0.602, 0.878] 0.070 [− 0.048, 0.161]
Age + IDH mutations 0.774 [0.658, 0.863] 0.784 [0.655, 0.880] 0.010 [− 0.097, 0.085]
IDH mutation prediction performance: AUC [95% CI]
Without WSI Predicted IDH Mutation Probability With WSI Predicted IDH Mutation Probability Difference
None 0.667 [0.532, 0.784]
Age 0.689 [0.552, 0.816] 0.726 [0.599, 0.845] 0.037 [− 0.053, 0.097]
Gender 0.536 [0.430, 0.643] 0.650 [0.507, 0.769] 0.114 [− 0.078, 0.240]
Race 0.567 [0.480, 0.650] 0.687 [0.560, 0.800] 0.120 [− 0.002, 0.229]
Primary diagnosis 0.519 [0.389, 0.641] 0.637 [0.472, 0.755] 0.118 [− 0.090, 0.261]
Age + Race 0.711 [0.585, 0.834] 0.739 [0.613, 0.856] 0.028 [− 0.051, 0.078]

95% confidence intervals were derived from 10,000 bootstrapping replications. Bold texts indicate the best performance for each column. * Indicates statistically significant difference (p < 0.05).